The Shotlee Journal
Browse Shotlee articles about GLP-1 Medications.
Showing 9 / 934 GLP-1 Medications articles
New data shows many patients cycle on and off GLP-1 medications. Discover why this approach may hinder long-term health and why tracking is essential.
As new weight-loss medications enter the UAE market, patients are questioning insurance coverage. We break down the realities of policy, medical necessity, and the future of metabolic health.
Rebel Wilson's transformation is more than a celebrity headline; it's a masterclass in metabolic health. Discover the role of GLP-1s, the science of consistency, and why moderation beats intensity.
As GLP-1 medications like Ozempic and Wegovy change dietary habits, U.S. farmers are pivoting to pulse crops to meet the surging demand for high-protein foods.
Is your GLP-1 medication affecting your mood? Discover the science behind anhedonia, the 'Ozempic personality' phenomenon, and what experts say about dopamine and metabolic health.
A leading gynaecologist at Aston Medical School is probing whether GLP-1 drugs like Ozempic and Mounjaro could transform care for women with PCOS. With a £60,000 NHS grant, Dr Shagaf Bakour aims to evaluate their effects on metabolic health and fertility. This investigation highlights hope for better treatment pathways amid rising interest in these weight loss jabs.
New research presented at Digestive Disease Week 2026 suggests a minimally invasive 'gut reset' procedure could help patients maintain weight loss after discontinuing GLP-1 medications like Ozempic and Wegovy. The findings address a major challenge in obesity treatment: weight regain after stopping therapy.
Tight insurance restrictions on obesity drugs are turning doctors into financial advisors and patients into strategists. With coverage limits on Zepbound favoring Wegovy, many are pivoting to compounded alternatives at $300/month versus $450 for brand names. Explore the real challenges and solutions from experts and patients.
Amazon One Medical has launched a new weight management program featuring GLP-1 medications, providing transparent pricing and dedicated primary care oversight. With GLP-1 pills starting at $25 per month with insurance or $149 cash-pay, and injectables at $299, this initiative addresses key barriers like cost. Available nationwide with rapid delivery, it builds on Amazon's growing healthcare ecosystem.
